Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Traxion Sab De Cv Ord Shs GRPOF

Grupo Traxion SAB de CV is a Mexico-based company engaged in the transportation sector. The Company provides logistics services within eight business areas: Fright, including intermodal and multimodal services, door-to-door, national and cross-border distribution, among others; Integrated logistics, including logistics management, aerial and maritime services and custom transportation support services; Warehousing, including dedicated storage, shared warehouses, packing and value-added services, such as labeling and products assembly; Logistics systems, including software for logistics management; Passenger transportation, including transportation of personnel and students; Special services, including rental of bus and vans; Moving, including national and international moving services, and Advertising, including custom transportation services during marketing campaigns. The Company operates through a number of group companies.


PINL:GRPOF - Post by User

Post by ScienceGirlon Mar 21, 2018 2:38pm
216 Views
Post# 27755446

TBP website - I have a question...

TBP website - I have a question...
I was reading the website today and I have a question regarding a point on the investors page.
Under "Why invest" they have the following points: Why Invest Tetra is the only company in North America that is working with prescription drug regulators (i.e., Health Canada and FDA) to conduct rigorous clinical trials by bringing pharmaceutical science to the world of medicinal cannabis. As cannabis is a known entity for treating chronic pain, Tetra is able to bypass the long and extensive Phase II clinical trials with Health Canada and have expediency with the FDA. One of the emerging trend in the opioid market is smokable medical marijuana which Tetra plans to bring its lead product PPP001 a smokable, natural medical marijuana to market for the treatment of chronic pain in cancer patients. While other global Pharmaceuticals have secured approval for cannabis derivatives, nobody has proven to regulators that smokable cannabis has any medical benefits. As the opioid epidemic affects millions in North America and continues to grow, there is an increasing demand for an alternative to opioids such as cannabis based drugs that will replace the toxic side effect profile of opioids. Tetra plans to develop a superior quality cannabinoid drug product through a scientific process which will create intellectual property which the company can protect via patents. In addition, Tetra plans on filing the IP for a device with a built-in mechanism for reducing drug abuse.
All good points, but I'm not quite sure what the last one refers to. Does it refer to the structure of the inhalation device for PP0001 (to prevent abuse/overdose) or something else altogether? Anyone know?
<< Previous
Bullboard Posts
Next >>